Seeking the “mother of blood” from human pluripotent stem cells: Are we there yet?
Induced pluripotent stem cells (iPSCs) hold great promise for the treatment of human diseases, including the failure of bone marrow. Incremental progress across the past three and half decades has brought us closer to making hematopoietic stem cells from iPSCs clinical solutions. A recent innovative...
Main Author: | Fei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2017-09-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304217300442 |
Similar Items
-
Targeted, homology-driven gene insertion in stem cells by ZFN-loaded ‘all-in-one’ lentiviral vectors
by: Yujia Cai, et al.
Published: (2016-06-01) -
Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
by: Jin-he Jiang, et al.
Published: (2024-01-01) -
Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
by: Sherida de Leeuw, et al.
Published: (2019-07-01) -
Modelling Mitochondrial Disease in Human Pluripotent Stem Cells: What Have We Learned?
by: Cameron L. McKnight, et al.
Published: (2021-07-01) -
Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
by: Takeshi Tokuyama, et al.
Published: (2021-09-01)